Nuvalent Inc - Class A — Dividend History & Yield (NASDAQ:NUVL) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Notícias

Nuvalent registra prejuízo no quarto trimestre enquanto aguarda decisão da FDA sobre medicamento para câncer de pulmão

Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug

Drugmakers turn to AI to speed trials, regulatory submissions

Ações da Nuvalent Inc atingem máxima de 52 semanas a US$ 112,89

Nuvalent Inc stock hits 52-week high at 112.89 USD

FDA aceita pedido da Nuvalent para tratamento de CPNPC positivo para ROS1

FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment

Nuvalent (NUVL) chief legal officer Miller sells $676k in stock

Nuvalent CSO Pelish sells shares worth $501,752

Nuvalent (NUVL) chief development officer sells $721k in stock

What's Going On With Royalty Pharma Stock Wednesday? - Royalty Pharma (NASDAQ:RPRX)

3 Biotech Stocks With Major 2026 Catalysts